These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1357399)

  • 1. Intraportal 5-fluorouracil for colorectal cancer: the AXIS trial.
    Garten L; Stenning S; Gray R
    Lancet; 1992 Oct; 340(8825):985. PubMed ID: 1357399
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adjuvant treatment of rectal carcinoma: also a step forward?].
    Wagener DJ; Wils JA
    Ned Tijdschr Geneeskd; 1992 Mar; 136(11):502-3. PubMed ID: 1552951
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronomodulated chemotherapy in advanced colorectal carcinoma.
    Price T; Karapetis C
    J Clin Oncol; 2002 Sep; 20(18):3937-8; author reply 3938-9. PubMed ID: 12228219
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma.
    Fielding LP; Hittinger R; Grace RH; Fry JS
    Lancet; 1992 Aug; 340(8818):502-6. PubMed ID: 1354275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current role of bevacizumab in colorectal cancer.
    Saltz L
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):375-6. PubMed ID: 19606071
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized multicenter trial of adjuvant intraportal chemotherapy for colorectal cancer (SAKK 40/81). An interim report.
    Metzger U; Laffer U; Aeberhard P; Arigoni M; Arma S; Barras J; Egeli R; Martinoli S; Mueller W; Schweizer W
    Acta Chir Scand; 1990; 156(6-7):467-74. PubMed ID: 2114722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of semustine plus weekly fluorouracil and high-dose leucovorin calcium in patients with advanced colorectal cancer.
    Abbruzzese JL; Weeks A; Raber MN; Gravel D; DuBrow RA; Levin B; Grem J; Chun HG
    J Natl Cancer Inst; 1989 Dec; 81(23):1840-2. PubMed ID: 2585532
    [No Abstract]   [Full Text] [Related]  

  • 8. [Can the occurrence of extrahepatic metastases in regional chemotherapy of the liver be prevented by adding systemic chemotherapy? A randomized multicenter study].
    Hottenrott C; Lorenz M
    Z Gastroenterol Verh; 1989 Jul; 24():199-201. PubMed ID: 2474952
    [No Abstract]   [Full Text] [Related]  

  • 9. First line protracted venous infusion fluorouracil with CisDDP or carboplatine in advanced colorectal cancer.
    Garcia-Giralt E; Omodei Zorini C; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    Clin Ter; 1997 Sep; 148(9):393-401. PubMed ID: 9374077
    [No Abstract]   [Full Text] [Related]  

  • 10. Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.
    Venook AP; Blanke CD; Niedzwiecki D; Lenz HJ; Taylor JR; Hollis DR; Sutherland S; Goldberg RM
    Clin Colorectal Cancer; 2007 May; 6(7):536-8. PubMed ID: 17553204
    [No Abstract]   [Full Text] [Related]  

  • 11. A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience.
    Xu N; Fang WJ; Zhang XC; Yu LF; Bao HY; Shi GM; Huang S; Shen P
    Cancer Invest; 2007; 25(7):599-605. PubMed ID: 17882631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in adjuvant chemotherapy for colorectal cancer.
    Knowles GH; Jodrell DI
    Eur J Cancer Care (Engl); 1997 Mar; 6(1):18-22. PubMed ID: 9238925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer.
    Punt CJ; Koopman M
    J Clin Oncol; 2008 Apr; 26(11):1907-8; author reply 1908-9. PubMed ID: 18398161
    [No Abstract]   [Full Text] [Related]  

  • 14. Should continuous infusion 5-fluorouracil become the standard of care in the USA as it is in Europe?
    El-Khoueiry AB; Lenz HJ
    Cancer Invest; 2006 Feb; 24(1):50-5. PubMed ID: 16466993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oxaliplatinum in combination with 5-FU/FA in first-line chemotherapy of metastatic colorectal cancer: a new era in therapeutic strategy].
    Tumori; 2000; 86(2):A1-4. PubMed ID: 10855861
    [No Abstract]   [Full Text] [Related]  

  • 16. Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.
    Xu RH; Muro K; Morita S; Iwasa S; Han SW; Wang W; Kotaka M; Nakamura M; Ahn JB; Deng YH; Kato T; Cho SH; Ba Y; Matsuoka H; Lee KW; Zhang T; Yamada Y; Sakamoto J; Park YS; Kim TW
    Lancet Oncol; 2018 May; 19(5):660-671. PubMed ID: 29555258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU.
    Rougier P; Nordlinger B
    Ann Oncol; 1993; 4 Suppl 2():21-8. PubMed ID: 8353101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.
    Rougier P; Van Cutsem E; Bajetta E; Niederle N; Possinger K; Labianca R; Navarro M; Morant R; Bleiberg H; Wils J; Awad L; Herait P; Jacques C
    Lancet; 1998 Oct; 352(9138):1407-12. PubMed ID: 9807986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).
    Muro K; Boku N; Shimada Y; Tsuji A; Sameshima S; Baba H; Satoh T; Denda T; Ina K; Nishina T; Yamaguchi K; Takiuchi H; Esaki T; Tokunaga S; Kuwano H; Komatsu Y; Watanabe M; Hyodo I; Morita S; Sugihara K
    Lancet Oncol; 2010 Sep; 11(9):853-60. PubMed ID: 20708966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands.
    Mol L; Koopman M; van Gils CW; Ottevanger PB; Punt CJ
    Acta Oncol; 2013 Jun; 52(5):950-5. PubMed ID: 23517248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.